| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INDIRECT ACCOUNTING FEES | 1,465 | 1,465 |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| O REILLY AUTOMOTIVE INC | 2009-12 | PURCHASE | 2023-10 | 17,950 | 793 | 17,157 | ||||
| VERTEX PHARMACEUTICALS INC | 2010-12 | PURCHASE | 2023-10 | 12,743 | 1,240 | 11,503 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| WELCH AND FORBES | FMV | 666,432 | 666,432 |
| Description | Amount |
|---|---|
| NET UNREALIZED (LOSS)/GAIN ON INVESTMENT | 50,158 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INVESTMENT FEES | 7,860 | 7,860 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FOREIGN TAXES | 64 | 64 |